Concepedia

Richard Dobrashian

RD

3

Publications

645

Citations

3

H-Index

2003

Active since

Affiliations

University of Manchester(Current)

Manchester University

Manchester Academic Health Science Centre

NIHR Manchester Biomedical Research Centre

Manchester University NHS Foundation Trust

Richard Dobrashian is an author at University of Manchester specializing in inflammatory lung disease, antifungal agents, and immunology.

Top concepts

MedicinePathologyImmunologyAntifungal AgentsLung InflammationPulmonary FibrosisInflammatory Lung Disease

Publications per year

2003–2023

3

Publications

3

Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review

David W. Denning, Kostantinos Riniotis, Richard Dobrashian et al. · Clinical Infectious Diseases · 2003 · 540 citations · Full text

Total Immunoglobulin E, Inflammatory Lung Disease, Lung Inflammation +16

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)

David French, Susan Astley, Adam R. Brentnall et al. · BMC Cancer · 2020 · 90 citations · Full text

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)

D. Gareth Evans, Lorna McWilliams, Susan Astley et al. · British Journal of Cancer · 2023 · 15 citations · Full text

Rows per page

1–3 of 3